CS logo
small CS logo
Fleming Island Center for Clinical Research

Fleming Island, Florida, United States
Research institute in Clay County, Florida
1679 Eagle Harbor Pkwy suite d, Fleming Island, FL 32003

About Fleming Island Center for Clinical Research


"We are a member site of ENCORE Research Group, a premier clinical research organization that has conducted more than 2,500 clinical trials over 20 years and has worldwide recognition for providing patients access to cutting edge medical research. If you have a medical issue and want a research solution, or if you are a healthy volunteer, come visit our center and learn more. One of our experts will be happy to evaluate you."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
6
Astellas Pharma Global Development, Inc.
2
Eisai Inc.
2
Idorsia Pharmaceuticals Ltd.
2
Angion Biomedica Corp
1
BioNTech SE
1
CardioKine Inc.
1
Ellodi Pharmaceuticals, LP
1
Enanta Pharmaceuticals, Inc
1
Iroko Pharmaceuticals, LLC
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Total Rows: 12

Clinical Trials at Fleming Island Center for Clinical Research


During the past decade, Fleming Island Center for Clinical Research conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 12 clinical trials were completed, i.e. on average, 92.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 8 clinical trials were completed. i.e. 160% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1122332222112200220011112233Started TrialsCompleted Trails201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430
2010-01-01
Completed
135
Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging Study
2010-03-30
2011-02-18
Terminated
385
A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
2011-05-01
2012-11-01
Completed
2,012
Study of Meloxicam Capsules to Treat Osteoarthritis Pain
2013-02-01
2013-10-01
Completed
403
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
2013-10-29
2017-07-10
Completed
2,139
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
2014-01-24
2018-05-14
Completed
14,673
Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass
2017-02-24
2021-08-01
Active, not recruiting
275

Rows per page:

1–20 of 20

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Fleming Island Center for Clinical Research" #1 sponsor was "Pfizer" with 6 trials, followed by "Astellas Pharma Global Development, Inc." with 2 trials sponsored, "Eisai Inc." with 2 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored and "Angion Biomedica Corp" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Fleming Island Center for Clinical Research" #1 collaborator was "Biogen" with 1 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Cardiokine Biopharma, LLC" with 1 trials as a collaborator, "Clinical Accelerator" with 1 trials as a collaborator and "Everest Clinical Research" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 6Pfizer: 6Astellas Pharma GlobalDevelopment, Inc.: 2Astellas Pharma GlobalDevelopment, Inc.: 2Eisai Inc.: 2Eisai Inc.: 2Idorsia Pharmaceuticals Ltd.: 2Idorsia Pharmaceuticals Ltd.: 2Angion Biomedica Corp: 1Angion Biomedica Corp: 1BioNTech SE: 1BioNTech SE: 1CardioKine Inc.: 1CardioKine Inc.: 1Ellodi Pharmaceuticals, LP: 1Ellodi Pharmaceuticals, LP: 1Enanta Pharmaceuticals, Inc: 1Enanta Pharmaceuticals, Inc: 1Iroko Pharmaceuticals, LLC: 1Iroko Pharmaceuticals, LLC: 1

Created with Highcharts 11.1.0Top CollaboratorsBiogen: 1Biogen: 1CTI Clinical Trial andConsulting Services: 1CTI Clinical Trial andConsulting Services: 1Cardiokine Biopharma, LLC: 1Cardiokine Biopharma, LLC: 1Clinical Accelerator: 1Clinical Accelerator: 1Everest Clinical Research: 1Everest Clinical Research: 1ICON Clinical Research: 1ICON Clinical Research: 1Pfizer: 1Pfizer: 1The Cleveland Clinic: 1The Cleveland Clinic: 1Thrombolysis InMyocardial Infarction(TIMI) AcademicResearch Organization:1Thrombolysis InMyocardial Infarction(TIMI) AcademicResearch Organization:1Triangle Biostatistics: 1Triangle Biostatistics: 1

Clinical Trials Conditions at Fleming Island Center for Clinical Research


According to Clinical.Site data, the most researched conditions in "Fleming Island Center for Clinical Research" are "Hot Flashes" (2 trials), "Influenza, Human" (2 trials), "Insomnia Disorder" (2 trials), "Osteoarthritis" (2 trials) and "Acute Kidney Injury" (1 trials). Many other conditions were trialed in "Fleming Island Center for Clinical Research" in a lesser frequency.

Clinical Trials Intervention Types at Fleming Island Center for Clinical Research


Most popular intervention types in "Fleming Island Center for Clinical Research" are "Drug" (14 trials), "Biological" (5 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "fezolinetant" (2 trials), "placebo" (2 trials), "ANG-3777" (1 trials) and "APT-1011" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Fleming Island Center for Clinical Research


The vast majority of trials in "Fleming Island Center for Clinical Research" are 18 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Fleming Island Center for Clinical Research


Currently, there are NaN active trials in "Fleming Island Center for Clinical Research". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Fleming Island Center for Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Fleming Island Center for Clinical Research, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 12Phase 3: 12Phase 2: 5Phase 2: 5Phase 4: 3Phase 4: 3Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 16Completed: 16Active, not recruiting: 3Active, not recruiting: 3Terminated: 1Terminated: 1